Scripps News speaks with vaccine experts who say HHS funding cuts targeting mRNA vaccines could hinder other vaccine research ...

( NewsNation) — National Institutes of Health director Jay Bhattacharya believes mRNA vaccine technology is “promising” but ...

The Trump administration’s COVID-revenge campaign has laid the groundwork for Kennedy’s larger agenda.

(Reuters) -Vaxart said on Wednesday it received an order to stop work on screening and enrollment for its COVID-19 mid-stage ...

The world’s first biodegradable vaccine for foot and mouth disease (FMD) has been developed in Australia, a country that ...

Federal funding cuts to mRNA technology research doesn't just impact COVID vaccines — experts say it could stall progress in ...

Health Secretary Robert F. Kennedy Jr.’s cut to funding for mRNA research will also hurt the nation’s reputation as a leader ...

RNA drugs might be able to protect against a huge range of viruses by turning on key parts of our innate defences against ...

Federal funding cuts to mRNA technology research doesn't just impact COVID vaccines — experts say it could stall progress in treatment for cancers, rare disease and more.

The NIH’s Jay Bhattacharya tried his best pitch to explain the Trump administration’s shift away from mRNA vaccine research.

Dr. David Wohl — an infectious disease researcher with UNC Health — speaks with 97.9 The Hill's Brighton McConnell on Wednesday, August 13.